|Mr. Dongchen Cai||Exec. Chairman, Chief Exec. Officer and Managing Director||N/A||N/A||63|
|Mr. Weidong Pan||Chief Accountant, Exec. Director and Director of Shijiazhuang Pharmaceutical Group Co. Limite||N/A||N/A||47|
|Mr. Kin Man Chak||Exec. Director||N/A||N/A||51|
|Dr. Shunlong Wang Ph.D.||Exec. Director||N/A||N/A||53|
|Mr. Huaiyu Wang||Exec. Director||N/A||N/A||54|
CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. It operates through Finished Drugs, Antibiotics, Vitamin C, and Caffeine and Others segments. The company offers finished drugs, such as NBP series used for acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning series to treat hypertension and angina pectoris; Duomeisu, a chemotherapy drug for lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; Ailineng for nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; and Nuolining, a small molecule targeted cancer drug. It also provides generic drugs, including Qingre Jiedu, Ganmao Qingre, Yin Huang, Xiangsha Yangwei, and Huoxiang Qushu soft capsules; Zhongnuo Shuluoke injection; Guoweikang health supplement products; antibiotics, vitamin C products, and caffeine and other drugs; and traditional Chinese medicines. In addition, the company has 170 products under research and development with focus on the therapeutic areas of cardio-cerebrovascular, diabetes, oncology, neurology, and anti-infection. Further, it provides pharmaceutical research and development services; storage, sourcing, and distribution services; and sewage and pharmaceutical by-products, as well as trades in pharmaceutical products and holds properties. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is headquartered in Shijiazhuang, the Peoples Republic of China.
CSPC Pharmaceutical Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.